<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01215318</url>
  </required_header>
  <id_info>
    <org_study_id>KEK-ZH-NR: 2010-0014</org_study_id>
    <nct_id>NCT01215318</nct_id>
  </id_info>
  <brief_title>FDG Uptake in Vaginal Tampons is Due to Urine</brief_title>
  <official_title>Source and Prevention of Urinary Contamination of Vaginal Tampons During 18F-2-fluoro-2-deoxy-D-glucose (FDG) Positron Emission Tomography (PET) Examinations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Irene Burger</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The etiology of FDG uptake in vaginal tampons during PET/CT examinations remains unclear and
      can potentially impair image interpretation.

      The aim of this study is to determine the etiology of this artefact and identify potential
      means how to prevent it.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this prospective, Institutional Review board approved study we included 44 women referred
      to FDG PET/CT for staging or follow-up in an oncology setting. All women were provided a
      normal commercial or modified vaginal tampon with a silicon coated base to be used during
      examination. Images were analyzed to determine the localization and the FDG uptake in the
      tampons. Between the uptake phase and imaging, all patients were asked to void. After image
      acquisition, tampons were individually analyzed for creatinine concentration, blood traces,
      position relative to the pubococcygeal line, and FDG activity. Statistical significance was
      determined by means of the Mann-Whitney U test.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2, 2010</start_date>
  <completion_date type="Actual">September 30, 2010</completion_date>
  <primary_completion_date type="Actual">August 2, 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>randomly assigned to either modified or unmodified tampons</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Number of FDG Positive Tampoons</measure>
    <time_frame>1 month</time_frame>
    <description>Number of FDG positive Tampoons with an SUV &gt; 3</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tampon Position Relative to the Pubococcygeal Line</measure>
    <time_frame>1 month</time_frame>
    <description>measure tampon position in regard to the pubococcygeal line to identify if positioning is responsible for urinary contamination.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>Modified vaginal tampons</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients using modified vaginal tampons during FDG PET/CT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Unmodified vaginal tampons</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients using unmodified vaginal tampons during FDG PET/CT</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>modified vaginal tampon</intervention_name>
    <description>modified vaginal tampons versus unmodified vaginal tampons, comparing the urinary contamination</description>
    <arm_group_label>Modified vaginal tampons</arm_group_label>
    <arm_group_label>Unmodified vaginal tampons</arm_group_label>
    <other_name>ObÂ® Regular; Johnson &amp; Johnson, with silicon seal</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria: premenopausal women with known or suspected malignancies who regularly
        used vaginal tampons during menstruation and thus were familiar with their use

        Exclusion criteria: No cervical or genital carcinoma. No vaginal infection.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>48 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>01 Studienregister MasterAdmins</last_name>
    <role>Study Director</role>
    <affiliation>UniversitaetsSpital Zuerich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>October 4, 2010</study_first_submitted>
  <study_first_submitted_qc>October 4, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2010</study_first_posted>
  <results_first_submitted>October 8, 2010</results_first_submitted>
  <results_first_submitted_qc>August 14, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">August 28, 2019</results_first_posted>
  <last_update_submitted>August 14, 2019</last_update_submitted>
  <last_update_submitted_qc>August 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Zurich</investigator_affiliation>
    <investigator_full_name>Irene Burger</investigator_full_name>
    <investigator_title>Attending physician</investigator_title>
  </responsible_party>
  <keyword>FDG PET/CT, vaginal tampon, urinary contamination, pitfall</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Silicon</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Premenopausal women referred for FDG PET/CT examination for staging or follow up of malign disease, were given a modified or unmodified vaginal tampon during the PET/CT examination.</recruitment_details>
      <pre_assignment_details>Women with urogenital carcinoma were excluded.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Modified Vaginal Tampons</title>
          <description>Patients wearing modified tampons during PET/CT</description>
        </group>
        <group group_id="P2">
          <title>Unmodified Vaginal Tampons</title>
          <description>Patients wearing unmodified vaginal tampons during FDG PET/CT</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Modified Vaginal Tampons</title>
          <description>Patients wearing modified vaginal tampons during PET/CT</description>
        </group>
        <group group_id="B2">
          <title>Unmodified Vaginal Tampons</title>
          <description>Patients wearing unmodified vaginal tampons during PET/CT</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="24"/>
            <count group_id="B3" value="44"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39" spread="7.7"/>
                    <measurement group_id="B2" value="37" spread="8.4"/>
                    <measurement group_id="B3" value="39" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Switzerland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of FDG Positive Tampoons</title>
        <description>Number of FDG positive Tampoons with an SUV &gt; 3</description>
        <time_frame>1 month</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Modified Vaginal Tampons</title>
            <description>Patients wearing modified tampons during FDG PET/CT</description>
          </group>
          <group group_id="O2">
            <title>Unmodified Vaginal Tampons</title>
            <description>Patients wearing unmodified tampons during FDG PET/CT</description>
          </group>
        </group_list>
        <measure>
          <title>Number of FDG Positive Tampoons</title>
          <description>Number of FDG positive Tampoons with an SUV &gt; 3</description>
          <units>FDG positive tampons</units>
          <param>Number</param>
          <units_analyzed>vaginal tampons</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>vaginal tampons</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tampon Position Relative to the Pubococcygeal Line</title>
        <description>measure tampon position in regard to the pubococcygeal line to identify if positioning is responsible for urinary contamination.</description>
        <time_frame>1 month</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Modified Vaginal Tampons</title>
            <description>Patients wearing modified vaginal tampon during PET/CT</description>
          </group>
          <group group_id="O2">
            <title>Unmodified Vaginal Tampons</title>
            <description>Patients wearing modified vaginal tampon during PET/CT</description>
          </group>
        </group_list>
        <measure>
          <title>Tampon Position Relative to the Pubococcygeal Line</title>
          <description>measure tampon position in regard to the pubococcygeal line to identify if positioning is responsible for urinary contamination.</description>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>vaginal tampons</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>vaginal tampons</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.9" spread="17"/>
                    <measurement group_id="O2" value="5.1" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>During FDG PET/CT scan (2 hours)</time_frame>
      <desc>Dyscomfort</desc>
      <group_list>
        <group group_id="E1">
          <title>Modified Vaginal Tampons</title>
          <description>Patients wearing modified vaginal tampon during PET/CT</description>
        </group>
        <group group_id="E2">
          <title>Unmodified Vaginal Tampons</title>
          <description>Patients wearing unmodified vaginal tampon during PET/CT</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>absence of gynecological examination. Vaginal tampon position was only assessed with respect to the pubococcygeal line visualized on computer tomography.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Irene A Burger</name_or_title>
      <organization>University Hospital of Zurich</organization>
      <phone>+41 44 255 11 11</phone>
      <email>irene.burger@usz.ch</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

